基本信息
浏览量:267
职业迁徙
个人简介
I oversee the clinical, research, and educational missions of the department and MSK Kids. I specialize in caring for my patients using cancer genomics (studying the genetic changes related to cancer), precision medicine (tailoring treatment to the biology of the disease), and stem cell transplantation. In my research, I focus on identifying the causes of pediatric cancers and developing new treatments to benefit children and teens with these diseases.
Cancer is a frightening diagnosis. It is especially devastating when it occurs in a young person. Because childhood cancers are rare, every child with cancer deserves to be treated in an academic medical center by a team with the experience and knowledge to offer the most-advanced therapies. I feel privileged to lead the dedicated faculty and staff of MSK Kids, which is the largest pediatric oncology program in the United States. We combine the deep expertise of our care teams with the latest scientific approaches to develop the best care plans for our patients while enhancing their well-being.
In my research, I use cutting-edge technologies to pinpoint the molecular roots of cancer and use that new information to improve pediatric cancer treatment. The knowledge we gain when we care for patients also helps drive discovery. My translational research is bidirectional. That means my team takes the latest scientific discoveries from the laboratory and applies them to the care of patients. In turn, how patients fare with their disease in response to treatment tells us what we need to explore in the lab.
As Chair, I am also responsible for advancing MSK’s mission to train the next generation of leaders in pediatric oncology as well as the physician-scientists who will pioneer the therapies of the future. Graduates from our esteemed fellowship program take the advanced knowledge and skills that they learn here to hospitals and industries around the world, spreading MSK’s expertise far beyond our walls to help children everywhere.
In all of these pursuits, my primary focus has been and will always be the care and well-being of our young patients. I feel honored to collaborate with colleagues who share this passion. It is a pleasure to work in an institution so strongly focused on providing exceptional care for children with cancer and blood disorders.
Cancer is a frightening diagnosis. It is especially devastating when it occurs in a young person. Because childhood cancers are rare, every child with cancer deserves to be treated in an academic medical center by a team with the experience and knowledge to offer the most-advanced therapies. I feel privileged to lead the dedicated faculty and staff of MSK Kids, which is the largest pediatric oncology program in the United States. We combine the deep expertise of our care teams with the latest scientific approaches to develop the best care plans for our patients while enhancing their well-being.
In my research, I use cutting-edge technologies to pinpoint the molecular roots of cancer and use that new information to improve pediatric cancer treatment. The knowledge we gain when we care for patients also helps drive discovery. My translational research is bidirectional. That means my team takes the latest scientific discoveries from the laboratory and applies them to the care of patients. In turn, how patients fare with their disease in response to treatment tells us what we need to explore in the lab.
As Chair, I am also responsible for advancing MSK’s mission to train the next generation of leaders in pediatric oncology as well as the physician-scientists who will pioneer the therapies of the future. Graduates from our esteemed fellowship program take the advanced knowledge and skills that they learn here to hospitals and industries around the world, spreading MSK’s expertise far beyond our walls to help children everywhere.
In all of these pursuits, my primary focus has been and will always be the care and well-being of our young patients. I feel honored to collaborate with colleagues who share this passion. It is a pleasure to work in an institution so strongly focused on providing exceptional care for children with cancer and blood disorders.
研究兴趣
论文共 554 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Scientific reportsno. 1 (2024)
Lauren Banks, Hadara Arkin,Smita S. Chandran,Emily K. Slotkin, Madelyn Espinosa-Cotton,Neerav Shukla, Luc G.T. Morris,Marc Ladanyi,Andrew L. Kung,Martin G. Klatt, Christopher A. Klebanoff
Cancer researchno. 6_Supplement (2024): 6-6
Cytotherapyno. 5 (2024): 466-471
crossref(2024)
Cancer Researchno. 6_Supplement (2024): 6227-6227
Transplantation and cellular therapyno. 2 (2024): S272-S273
CANCER RESEARCHno. 6 (2024): 901-901
Chelsey Burke, Ferreira,Glorymar Ibanez,Daoqi You,Andoyo A Ndengu,Paul Calder,Kristina Guillan,Armaan Siddiquee,Nestor Rosales,Matthew Long, Raina Fishkin, Samantha Brosius, Tamar Y Feinberg,Emily K Slotkin,Michael Vincent Ortiz,Andrew Kung,Filemon S Dela Cruz
Journal of Clinical Oncologyno. 16_suppl (2024): 10049-10049
crossref(2024)
crossref(2024)
加载更多
作者统计
#Papers: 551
#Citation: 42455
H-Index: 98
G-Index: 203
Sociability: 9
Diversity: 0
Activity: 4
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn